Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07492927 · ClinicalTrials.gov registry record
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
A clinical trial, sponsored by Xijing Hospital.
- Recruiting
- Registry status
- 1,700
- Enrollment target
NCT07492927 is a clinical trial that is actively recruiting participants, run by Xijing Hospital. The registered enrollment target is 1,700 participants.
The verdict
NCT07492927 is actively recruiting participants, sponsored by Xijing Hospital.
- RECRUITING
- Registry status
- 1,700 participants
- Enrollment target
Study Summary
The aim of the present study is to investigate a plasma exosome RNA signature to diagnose clinically significant prostate cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07492927
The ClinicalTrials.gov registry entry for NCT07492927 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xijing Hospital, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07492927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07492927 about?
NCT07492927 is a clinical study titled "Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer". The aim of the present study is to investigate a plasma exosome RNA signature to diagnose clinically significant prostate cancer.
What is the current status of trial NCT07492927?
This trial is currently recruiting. The enrollment target is 1,700 participants. The study started on 2021-03-12. Estimated completion is 2027-06-30.
Who is sponsoring clinical trial NCT07492927?
This trial is sponsored by Xijing Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.